Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Kouroukis

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Annals of Hematology|January 5, 2002
Treatment strategies in elderly patients with aggressive histology lymphomaC T Kouroukis, R M Meyer
The Journal of Frailty & Aging|October 23, 2019
Comparison of Frailty Scores in Newly Diagnosed Patients with Multiple Myeloma: A ReviewHira Mian, M Brouwers, C T Kouroukis, et al.
Current Oncology (Toronto, Ont.)|October 17, 2007
Canadian supportive care recommendations for the management of anemia in patients with cancerJ Mikhael, B Melosky, C Cripps, et al.
Current Oncology (Toronto, Ont.)|August 19, 2016
Plerixafor for autologous stem-cell mobilization and transplantation for patients in OntarioC T Kouroukis, N P Varela, C Bredeson, et al.
Current Oncology (Toronto, Ont.)|April 26, 2014
Extracorporeal photopheresis in the management of graft-versus-host diseaseC Bredeson, R B Rumble, N P Varela, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 18, 2016
Rituximab in Lymphoma and Chronic Lymphocytic Leukaemia: A Practice GuidelineA Prica, F Baldassarre, L K Hicks, et al.
Current Oncology (Toronto, Ont.)|March 5, 2008
Canadian supportive care recommendations for the management of neutropenia in patients with cancerC T Kouroukis, S Chia, S Verma, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 11, 2013
Bortezomib in multiple myeloma: a practice guidelineC T Kouroukis, F G Baldassarre, A E Haynes, et al.
BMC Cancer|August 9, 2024
Feasibility of collecting longitudinal patient-reported outcomes in individuals with relapsed or refractory large B-cell lymphoma who received chimeric antigen receptor T-cell (CART) therapyAmaris Balitsky, G R Pond, G A Davies, et al.
Leukemia|September 16, 1998
PML/RAR alpha APL with undifferentiated morphology and stem cell immunophenotypeR Foley, P Soamboonsrup, T Kouroukis, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Annals of Hematology|January 5, 2002
Treatment strategies in elderly patients with aggressive histology lymphomaC T Kouroukis, R M Meyer
The Journal of Frailty & Aging|October 23, 2019
Comparison of Frailty Scores in Newly Diagnosed Patients with Multiple Myeloma: A ReviewHira Mian, M Brouwers, C T Kouroukis, et al.
Current Oncology (Toronto, Ont.)|October 17, 2007
Canadian supportive care recommendations for the management of anemia in patients with cancerJ Mikhael, B Melosky, C Cripps, et al.
Current Oncology (Toronto, Ont.)|August 19, 2016
Plerixafor for autologous stem-cell mobilization and transplantation for patients in OntarioC T Kouroukis, N P Varela, C Bredeson, et al.
Current Oncology (Toronto, Ont.)|April 26, 2014
Extracorporeal photopheresis in the management of graft-versus-host diseaseC Bredeson, R B Rumble, N P Varela, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 18, 2016
Rituximab in Lymphoma and Chronic Lymphocytic Leukaemia: A Practice GuidelineA Prica, F Baldassarre, L K Hicks, et al.
Current Oncology (Toronto, Ont.)|March 5, 2008
Canadian supportive care recommendations for the management of neutropenia in patients with cancerC T Kouroukis, S Chia, S Verma, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 11, 2013
Bortezomib in multiple myeloma: a practice guidelineC T Kouroukis, F G Baldassarre, A E Haynes, et al.
BMC Cancer|August 9, 2024
Feasibility of collecting longitudinal patient-reported outcomes in individuals with relapsed or refractory large B-cell lymphoma who received chimeric antigen receptor T-cell (CART) therapyAmaris Balitsky, G R Pond, G A Davies, et al.
Leukemia|September 16, 1998
PML/RAR alpha APL with undifferentiated morphology and stem cell immunophenotypeR Foley, P Soamboonsrup, T Kouroukis, et al.
Pageof 2